Lack of neuronal damage in atypical absence status epilepticus

Epilepsia

Volumn 43, Issue 12, 2002, Pages 1498-1501

  Shirasaka, Yukiyoshi ^a,b  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Absence status epilepticus; Cerebrospinal fluid; Complex partial status epilepticus; Neuron specific enolase; Neuronal damage

Indexed keywords

DIAZEPAM; NEURON SPECIFIC ENOLASE;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHILD; CHROMOSOME ANALYSIS; COMPLEX PARTIAL SEIZURE; CONSCIOUSNESS DISORDER; DISEASE DURATION; ELECTROENCEPHALOGRAM; ENZYME ASSAY; ENZYME BLOOD LEVEL; EPILEPTIC DISCHARGE; EPILEPTIC STATE; FEMALE; HUMAN; MALE; NERVE CELL LESION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE; SYMPTOMATOLOGY;

ADOLESCENT; BRAIN DAMAGE, CHRONIC; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; EPILEPSY, COMPLEX PARTIAL; FEMALE; HUMANS; MALE; NEUROLOGIC EXAMINATION; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; STATUS EPILEPTICUS;

EID: 0036896623     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.10502.x     Document Type: Article

References (15)

1. Wasterlain CG, Shirasaka Y. Seizures, brain damage and brain development. Brain Dev 1994;16:279.
2. Olney JW, Rhee V, Ho OL. Kainic acid: A powerful neurotoxic analogue of glutamate. Brain Res 1974;77:507.
3. MacDermott AB, Mayer ML, Westbrook GL, et al. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 1986;321:519.
4. Fountain NB. Status epilepticus: Risk factors and complications. Epilepsia 2000;41(suppl 2):s23.
5. Cendes F, Andermann F, Carpenter S, et al. Temporal lobe epilepsy caused by domoic acid intoxication: Evidence for glutamate receptor-mediated excitotoxicity in humans. Ann Neurol 1995;37: 123.
6. Krumholz A. Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Nuerophysiol 1999;16:314.
7. Aicardi J. Epilepsy in Children. 2nd Ed. New York: Raven Press, 1994.
8. Rabinowicz AL, Correale JD, Couldwell WT, et al. CSF neuronspecific enolase after methohexital activation during electrocorticography. Neurology 1994;44:1167.
9. Correale JD, Rabinowicz AL, Heck CN, et al. Status epilepticus increases CSF level of neuron-specific enolase and alters the blood-brain barrier. Neurology 1998;50:1388.
10. Hosford DA. Animal model of nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16:306.
11. O'Regan ME, Brown JK. Serum neuron specific enolase: A marker for neuronal dysfunction in children with continuous EEG epileptiform activity. Eur J Paediatr Neurol 1998;2:193.
12. DeGiorgio CM, Heck CN, Rabinowicz AL, et al. Serum neuronspecific enolase in the major subtypes of status epilepticus. Neurology 1999;52:746.
13. Collzos J, Esteban C, Fernandez A, et al. Measurement of the serum tumor marker neuron-specific enolase in patients with benign pulmonary diseases. Am J Respir Crit Care Med 1994;150: 143.
14. Szturmowicz M, Burakowski J, Tomkowski W, et al. Neuronspecific enolase in non-neoplastic lung diseases, a marker of hypoxemia? Int J Biol Markers 1998;13:150.
15. Kaplan PW. No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: "the cure may be worse than the disease"). Neurophysiol Clin 2000;30:377.